The aim of this study is to characterise the choroidal features of patients diagnosed with sarcoid- and tuberculosis (TB)-associated granulomatous uveitis using spectral domain optical coherence ...

Sirolimus may be an effective treatment for patients with persistent cutaneous sarcoidosis. In a small clinical trial, 7 of 10 patients treated with sirolimus via oral solution had improvements in ...

The clinical implications of the diagnosis of sarcoidosis go well beyond the labeling of a syndrome. This is true not only because the etiology is yet to be determined but also because the clinical ...

CHICAGO--(BUSINESS WIRE)--Xentria Inc., a biotech company focused on developing novel biologics to address unmet clinical needs, today announced that a new abstract showcasing XTMAB-16’s potential ...

CHICAGO--(BUSINESS WIRE)--Xentria Inc., a biotech company focused on developing novel biologics to address unmet clinical needs, presented its first set of data showing its novel biologic, XTMAB-16, ...

Granulomas are tissue nodules of immune cells that occur in diseases such as tuberculosis and sarcoidosis and can damage many organs. For the first time, a team of researchers has identified what ...

Sarcoidosis is a granulomatous disease that affects a number of different organ systems to varying degrees, but most often affects the lungs. Other susceptible sites include the heart, skin, eyes, ...

Please provide your email address to receive an email when new articles are posted on . Approximately 40,000 people in the United States have skin sarcoidosis and there is no FDA-approved treatment.

About one in a thousand people get sarcoidosis and many may not realize they have it. But pulmonologist Dr. Gary Weinstein with Texas Health Dallas told KERA’s Sam Baker the inflammatory disease can ...